欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/2625/002
药品名称Fluticasona + Salmeterol Genetic
活性成分
    • fluticasone 125.0 µg/dose
    • salmeterol 25.0 µg/dose
剂型Pressurised inhalation, suspension
上市许可持有人Zentiva Portugal, Lda
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Denmark (DK)
    • Italy (IT)
    • Sweden (SE)
    • Poland (PL)
许可日期2021/09/22
最近更新日期2024/04/29
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase